A Stanford-led team developed a machine-learning model that predicts donor death timing, reducing canceled liver transplants and improving resource use.
Key Details
- 1A machine-learning model predicts whether donors will die within 30–45 minutes after life support removal, enabling timely liver transplantation.
- 2The model was trained on over 2,000 cases from six US transplant centers and outperformed surgeons’ judgment (75% vs 65% accuracy).
- 3Futile procurement rates (resources spent without a successful transplant) dropped by 60% using the model.
- 4Missed transplant opportunities remained similar to surgeon judgment (just over 15%), but further model refinements lowered this to ~10% in recent tests.
- 5The model incorporates donor demographics, vitals, lab results, ventilator settings, and neurological assessments, and features a natural language interface for clinical data extraction.
- 6It is customizable to clinical and hospital preferences and is being adapted for heart and lung transplantation.
Why It Matters
This research demonstrates the growing potential of machine learning in high-stakes surgical decision-making, supporting better allocation of scarce organs and healthcare resources. Increased accuracy and efficiency can enhance patient outcomes, reduce waste, and potentially expand AI's role into more imaging-driven and perioperative workflows.
Source
EurekAlert
Related News
•EurekAlert
New VIS-Fb Nanobody Probes Transform High-Precision Cellular Imaging
Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.